NASDAQ · TELA
TELA Bio, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for TELA: Nov 12, 2026
TELA Bio, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.19. The reported EPS for the same quarter last year was $-0.19.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Dec 2026 | $-0.16 | $-0.16 | $-0.16 | 1 |
| Mar 2027 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Jun 2027 | $-0.11 | $-0.11 | $-0.11 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel · The Motley Fool · Zacks- RTTNews · Oct 9, 1:37 PM EDTWeekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data(RTTNews) – This week, biopharmaceutical companies saw a busy week of regulatory decisions, strategic partnerships and clinical developments, alongside pipeline setbacks and workforce reductions.
- RTTNews · Oct 5, 8:44 AM EDTTELA Bio Wins FDA 510(k) Clearance For Fully Resorbable Liora Scaffold(RTTNews) – On Monday, TELA Bio Inc. (TELA), a commercial-stage medical technology company focused on soft-tissue reconstruction, has received FDA 510(k) clearance for its Liora Monofilament Scaffold.
- RTTNews · Oct 5, 8:26 AM EDTTELA Bio Says FDA Grants 510(k) Clearance For Liora Monofilament Scaffold Product(RTTNews) – Medical technology company TELA Bio, Inc. (TELA) announced Monday that its Liora Monofilament Scaffold product was granted 510(k) clearance by the U.S. Food and Drug Administration.
- Fintel · Sep 25, 8:46 PM EDTCraig-Hallum Initiates Coverage of TELA Bio at BuyFintel reports that on September 25, 2026, Craig-Hallum initiated coverage of TELA Bio (NASDAQGM:TELA) with a Buy recommendation. On the same day, September 25, 2026, the latest closing price for TELA Bio was $1.28, following a pre-action close of $1.27 on September 24, 2026. Ove
- The Motley Fool · Aug 19, 9:01 AM EDTTELA Bio (TELA) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 10, 5:55 PM EDTTELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue EstimatesTELA Bio (TELA) delivered earnings and revenue surprises of -17.65% and -3.55%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 7:10 PM EDTPuma Biotech (PBYI) Q2 Earnings and Revenues Top EstimatesPuma Biotech (PBYI) delivered earnings and revenue surprises of +90.00% and +6.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 4, 8:35 AM EDTTELA Bio Names Heather Getz CEO(RTTNews) – On Tuesday, TELA Bio, Inc. (TELA), a commercial-stage medical technology company for soft tissue reconstruction, announced the appointment of Heather Getz as Chief Executive Officer and Director, effective today.
- Zacks · May 12, 5:15 PM EDTTELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue EstimatesTELA Bio (TELA) delivered earnings and revenue surprises of -50.00% and +3.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 11, 5:25 PM EDTAbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue EstimatesABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of +36.36% and +68.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 7, 5:25 PM EDTBridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue EstimatesBridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -19.32% and +8.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Mar 24, 6:01 PM EDTTELA Bio (TELA) Q4 2025 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for TELA Bio, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.